DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sun Pharma Share Price Live Updates: Sun Pharma's Stock Update

Economic Times 3 hrs ago·1 Oct 2026, 3:21 am

Sun Pharma's share price is currently being tracked by investors following a period of market volatility. The stock has seen significant movement, reflecting broader market sentiment and investor reactions to the company's recent performance and future outlook.

This fluctuation is important for investors as it signals shifting perceptions regarding the pharmaceutical giant's growth trajectory. The price action highlights the stock's sensitivity to both sector-specific trends and general market conditions.

Investors should monitor upcoming earnings reports and broader market trends to gauge the stock's next direction. Keeping an eye on these factors will help assess the stock's stability and potential for future growth.